11.06.2013 Views

Incidence, Distribution and Characteristics of Major Tomato Leaf ...

Incidence, Distribution and Characteristics of Major Tomato Leaf ...

Incidence, Distribution and Characteristics of Major Tomato Leaf ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Incidence</strong>, distribution <strong>and</strong> characteristics <strong>of</strong> major tomato leaf curl <strong>and</strong> mosaic virus diseases 134<br />

5.3.2.1 <strong>Tomato</strong> Yellow <strong>Leaf</strong> Curl Virus (sensu lato) <strong>Incidence</strong> <strong>and</strong><br />

Spread under Different Experimental Treatments<br />

5.3.2.1.1 <strong>Tomato</strong> Yellow <strong>Leaf</strong> Curl Virus <strong>Incidence</strong><br />

Taking all three trials, i.e. I (March-July 1999), II (August – Nov.1999), <strong>and</strong> III<br />

(Nov.1999 – February 2000), there was less TYLCV disease incidence in trial II <strong>and</strong><br />

III than in trial I due to a dual effect consisting <strong>of</strong> treatment effects (n1-n6) in Figure<br />

5.12, <strong>and</strong> weather changes, as shown also in figure 5.13. Thus, during trial I (Figure<br />

5.10), disease progress curves with sigmoid-like pattern were observed for all<br />

treatment plots except for plots with tomato-bean intercrop <strong>and</strong> no dimethoate<br />

application (n3), which produced a pattern characteristic <strong>of</strong> a monocyclic disease<br />

spread (Thresh, 1998). A monocyclic disease starts <strong>of</strong>f with a direct increase in<br />

number <strong>of</strong> infected plants over time, but gradually slows down <strong>and</strong> stabilizes at a<br />

certain level without rising again. From the results, it was clear that uprooting<br />

combined with dimethoate (n5), which had a significantly low disease incidence curve<br />

(Figure 5.10), was the most effective in controlling TYLCV. The same treatment (n5)<br />

also had low disease incidence in August to November 1999 (trial II) as shown in<br />

figure 5.11

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!